| Tunable electroconductive decellularized extracellular matrix hydrogels for engineering human cardiac microphysiological systems JH Tsui, A Leonard, ND Camp, JT Long, ZY Nawas, R Chavanachat, ... Biomaterials 272, 120764, 2021 | 69 | 2021 |
| Spatiotemporal control of cardiac anisotropy using dynamic nanotopographic cues PY Mengsteab, K Uto, AST Smith, S Frankel, E Fisher, Z Nawas, ... Biomaterials 86, 1-10, 2016 | 65 | 2016 |
| A subset of cytotoxic effector memory T cells enhances CAR T cell efficacy in a model of pancreatic ductal adenocarcinoma V Konduri, SK Joseph, TT Byrd, Z Nawas, J Vazquez-Perez, CJ Hofferek, ... Science translational medicine 13 (592), eabc3196, 2021 | 14 | 2021 |
| Functional maturation of human iPSC-based cardiac microphysiological systems with tunable electroconductive decellularized extracellular matrices JH Tsui, A Leonard, ND Camp, JT Long, ZY Nawas, R Chavanachat, ... BioRxiv, 786657, 2019 | 3 | 2019 |
| Modulation of inhibitory receptor signaling pathways improves CAR T cell activity against glioblastoma K Sanber, Z Nawas, V Salsman, A Gad, P Mathew, D Landi, C Lee, ... Cytotherapy 22 (5), S19-S20, 2020 | 1 | 2020 |
| Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial M Hegde, S Navai, C DeRenzo, SK Joseph, K Sanber, M Wu, AZ Gad, ... Nature Cancer, 1-15, 2024 | | 2024 |
| Engaging c-MET (mesenchymal-epithelial transition factor) Axis to Enhance the Safety and Antitumor Function of HER2-CAR T-Cells in Sarcoma M Choe, M Campbell, K Sanber, Z Nawas, R Brock, J Morris, AZ Gad, ... 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | | 2023 |
| Autologous HER2-specific CAR T-cells after lymphodepletion for advanced sarcoma M Hegde, S Navai, C DeRenzo, S Joseph, K Sanber, MF Wu, K Janeway, ... | | 2023 |
| 412 Synthetic PD-1 co-stimulatory molecule preserves a cytolytic CAR T cell immune synapse while reducing tonic signaling R Brock, J Morris, A Gad, D Landi, S Navai, Z Nawas, S Joseph, N Ahmed, ... J Immunother 10 (2), A1-A1595, 2022 | | 2022 |
| A Unique Subset of Cytotoxic Effector Memory T Cells Enhances the Efficacy of CAR T Cell Therapy in a Model of Pancreatic Ductal Adenocarcinoma V Konduri, S Joseph, T Byrd, M Halpert, Z Nawas, J Vazquez-Perez, ... PANCREAS 50 (7), 1072-1072, 2021 | | 2021 |
| CRISPR-Cas9 gene editing of inhibitory receptor signaling pathways improves CAR T cell activity against glioblastoma K Sanber, Z Nawas, V Salsman, A Gad, PR Matthew, D Landi, C Lee, ... Cancer Research 80 (16), 2020 | | 2020 |
| OSTEOSARCOMA EXHIBITS PATTERN OF PROTEOMIC ALTERATIONS IN RESPONSE TO HER2-SPECIFIC CAR T CELLS M Campbell, K Sanber, Z Nawas, S Joseph, K Rajapakshe, C Coarfa, ... PEDIATRIC BLOOD & CANCER 67, S124-S125, 2020 | | 2020 |
| Modulation of inhibitory signals in CAR T cells leads to improved activity against glioblastoma. K Sanber, Z Nawas, V Salsman, A Gad, P Matthew, C Lee, S Joseph, ... Journal of Clinical Oncology 38 (15_suppl), 3031-3031, 2020 | | 2020 |
| Bioprinting 3-Dimensional Skeletal Muscle Tissue Models Using Decellularized Extracellular Matrix ZY Nawas | | 2017 |
| Dynamically tunable nanotopographical surface for guided cardiomyocyte monolayer contraction PY Mengsteab, K Uto, AT Smith, S Frankel, E Fisher, Z Nawas, H Ding, ... 19th International Conference on Miniaturized Systems for Chemistry and Life …, 2015 | | 2015 |
